Model analysis for oral absorption of a drug/cyclodextrin complex involving competitive inclusion complexes

Journal of Inclusion Phenomena

Volumn 44, Issue 1-4, 2002, Pages 93-96

  Ono, Naomi ^a,b   Hirayama, Fumitoshi ^b   Arima, Hidetoshi ^b   Uekama, Kaneto ^b   Rytting, J Howard ^a  

^a UNIVERSITY OF KANSAS   (United States)

^b KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Bioavailability; Competitive inclusion; Competitor; Intestinal absorption; Permeation rate; Phenacetin

Indexed keywords

ANTIPYRETIC AGENT; CYCLODEXTRIN; PHENACETIN;

ANIMAL CELL; ARTIFICIAL MEMBRANE; BILE DUCT; CALCULATION; CANNULATION; COMPARATIVE STUDY; COMPETITIVE INHIBITION; CONFERENCE PAPER; CONTROLLED STUDY; DRUG ABSORPTION; DRUG DESIGN; DRUG EFFECT; DRUG FORMULATION; DRUG PENETRATION; HOST; IN VITRO STUDY; IN VIVO STUDY; INTESTINE ABSORPTION; MALE; MOLECULE; NONHUMAN; PHYSICAL CHEMISTRY; PHYSIOLOGY; RAT;

EID: 0347026168     PISSN: 09230750     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1023037016997     Document Type: Conference Paper

References (8)

1. K. Uekama, F. Hirayama, and T. Irie: Chem. Rev. 98, 2045 (1998).
2. V.J. Stella, V.M. Rao, E.A. Zannou, and V. Zia: Adv. Drug Deliv. Rev. 36, 3 (1999).
3. T. Tokumura, M. Nanba, Y. Tsushima, K. Tatsuishi, M. Kayano, Y. Machida, and T. Nagai: J. Pharm. Sci. 75, 391 (1986).
4. A. Ohki, M. Takagi, and K. Ueno: Chem. Lett., 1591 (1980).
5. K. Hosoya, H. Kubo, H. Natsume, K. Sugibayashi, Y. Morimoto, and S. Yamashita: Biopharm. Drug Disp. 14, 685 (1993).
6. G.G. Duggin: J. Chromatogr. 121, 156 (1976).
7. N. Ono, H. Arima, F. Hirayama, and K. Uekama: Eur. J. Pharm. Sci. 8, 133 (1999).
8. K. Nakanishi, M. Masada, T. Nadai, and K. Miyajima: Chem. Pharm. Bull. 37, 211 (1989).